Health-related quality of life in family members of patients with an advanced cancer diagnosis: A one-year prospective study

Sjolander, Catarina; Rolander, Bo; Järhult, Johannes; Mårtensson, Jan; Ahlstrom, Gerd

doi:10.1186/1477-7525-10-89

Table 4 HRQOL scores by partners (n = 26) and children (n = 8) at 3 to 15 months (n = 36)

	A1 Md	A1 M [SE]	p-value	A2 Md	A2 M [SE]	p-value	A3 Md	A3 M [SE]	p-value	A4 Md	A4 M [SE]	p-value	A5 Md	A5 M [SE]	p-value
PCS
Partners	41	43 [±2.2]	0.015*	46	44 [±2.2]	0.006**	43	42 [±2.1]	0.019*	44	41 [±2.2]	<0.001***	48	44 [±2.1]	0.002**
Children	55	54 [±3.4]		57	58 [±1.8]		56	55 [±1.9]		56	56 [±7]		57	58 [±3.9]
PF
Partners	75	74 [±2.8]	0.002**	80	77 [±4.1]	0.001**	73	73 [±3.8]	0.007**	75	72 [±3.8]	#	80	75 [±4.3]	0.001**
Children	100	89 [±9.9]		100	99 [±1.3]		100	94 [±4.9]		100	100 [±0.0]		100	98 [±1.5]
RP
Partners	50	54 [±7.8]	0.181	75	66 [±8.4]	0.010*	50	53 [±9.2]	0.007**	63	57 [±8.6]	<0.001***	75	63 [±8.2]	0.001**
Children	100	84 [±8.1]		100	97 [±3.1]		100	84 [±12.4]		100	81 [±12.3]		100	82 [±14.1]
BP
Partners	41	56 [±5.7]	0.074	62	62 [±5.7]	0.175	51	55 [±4.5]	0.060	41	52 [4.9]	<0.007**	51	58 [±4.3]	0.004**
Children	92	82 [±8.0]		78	78 [±7.8]		92	81 [±8.4]		100	87 [±10.9]		100	89 [±8.4]
GH
Partners	57	59 [±4.2]	0.283	67	60 [±4.2]	0.205	62	56 [±3.2]	0.019*	60	56 [±3.8]	0.020*	67	61 [±4.0]	0.034*
Children	67	67 [±5.8]		70	72 [±2.7]		80	73 [±8.0]		80	78 [±7.0]		87	82 [±6.7]
VT
Partners	58	54 [±4.1]	0.148	55	59 [±4.3]	0.502	50	54 [±3.8]	0.413	60	55 [±5.0]	0.596	60	56 [±4.0]	0.567
Children	45	42 [±4.3]		58	50 [±10.8]		65	59 [±10.5]		58	62 [±5.5]		70	60 [±8.6]
SF
Partners	88	76 [±5.4]	0.383	100	84 [±4.6]	0.043	69	72 [±4.3]	0.804	75	78 [±4.5]	0.983	88	81 [±4.7]	0.226
Children	75	72 [±7.4]		56	61 [±11.4]		69	69 [±9.4]		88	77 [±10.1]		75	66 [±10.8]
RE
Partners	50	53 [±8.9]	0.222	78	75 [±7.0]	0.258	83	61 [±8.9]	0.850	100	74 [±7.2]	0.709	67	60 [±8.8]	0.729
Children	100	75 [±13.7]		67	54 [±17.7]		83	58 [±17.5]		100	83 [±8.9]		75	66 [±10.8]
MH
Partners	68	65 [±4.1]	0.103	68	69 [±4.5]	0.148	60	62 [±3.7]	0.881	68	65 [±4.0]	0.919	72	66 [±4.2]	0.749
Children	51	53 [±6.3]		46	54 [±10.0]		74	70 [±9.6]		73	65 [±7.8]		100	67 [±17.8]
EQ-5D Index
Partners	0.73	0.70 [±0.46]	0.068	0.76	0.76 [±0.04]	0.680	0.73	0.70 [±0.04]	0.011*	0.76	0.69 [±0.04]	0.002**	0.73	0.67 [±0.05]	0.001**
Children	0.85	0.85 [±0.07]		0.84	0.73 [±0.09]		0.92	0.89 [±0.05]		0.85	0.89 [±0.04]		0.85	0.86 [±0.03]
EQ-5D VAS
Partners	75	73 [±2.8]	0.415	80	76 [±2.8]	0.318	75	71 [±2.9]	0.365	75	70 [±3.5]	0.107	79	71 [±3.7]	0.292
Children	78	72 [±10.3]		67	65 [±8.7]		83	73 [±9.6]		78	81 [±3.8]		63	65 [±6.5]

Independent Samples Mann–Whitney U Test * p <0.05, ** p <0.01, *** p <0.001.
A1 = 3 months, A2 = 6 months, A3 = 9 months, A4 = 12 months, A5 = 15 months.
PCS = Physical Component Summary Score, MCS = Mental Component Summary Score PF = Physical Functioning, RP = Role Physical, BP = Bodily Pain, GH = General Health, VT = Vitality, SF = Social Functioning, RE = Role Emotional, MH = Mental Health, EQ-5D Index = EQ-5D Index score, EQ-5D VAS = EQ-5D Visual analog scale.
# Not tested because values for children are constant (=100).

Back to article page

ISSN: 1477-7525

Contact us

Submission enquiries: journalsubmissions@springernature.com

Health and Quality of Life Outcomes

Contact us